Prospective Comparative Study Evaluating the Early Complications of Robot-assisted Radical Prostatectomy Performed as an Outpatient Versus an Inpatient Procedure.

NCT ID: NCT06822452

Last Updated: 2025-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

510 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-30

Study Completion Date

2030-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to demonstrate that outpatient management for robotic-assisted radical prostatectomy is not inferior to inpatient management in terms of the occurrence of early post-operative complications.

Researchers will compare outpatient robot-assisted radical prostatectomy to inpatient procedure.

Participants will:

* Visit the clinic after the operation once at 45 days, 6 months and once a year for up to 5 years for check-ups and tests.
* Answer survey questions about urinary and erectil functions, stress and anxiety, satisfaction, quality of life for 6 months
* Keep a diary to record procedures and treatments related to the care provided

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer Surgery Ambulatory Care Outpatient Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Outpatient procedure

Group Type EXPERIMENTAL

radical prostatectomy

Intervention Type PROCEDURE

Robot-assisted

Inpatient procedure

Group Type ACTIVE_COMPARATOR

radical prostatectomy

Intervention Type PROCEDURE

Robot-assisted

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

radical prostatectomy

Robot-assisted

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male, aged 18 and over
* Patient with prostate cancer for which the multidisciplinary meeting has proposed radical prostatectomy as a therapeutic option (with or without lymphadenectomy)
* Patient eligible for outpatient treatment :

1. The patient undertakes to comply with all medical instructions given during surgical consultations and the anaesthetic consultation.
2. The patient has access to personal transport allowing, if necessary, return to the facility or another approved facility (transport time and distance from the facility are not exclusion factors)
3. The patient has access to telephone communication facilities.
4. The patient undertakes not to drive a vehicle and to be accompanied on his return home and for the next 24 hours by a responsible person who will be familiar with the monitoring instructions.
5. The patient plans to remain in hospital overnight if this is deemed necessary by the department's doctors (operator and anaesthetist). The patient accepts this mode of care and its constraints.
* Participant affiliated to or benefiting from a social security scheme
* The participant has been informed and has given his/her free, informed and written consent (at the latest on the day of inclusion and before any examination required by the research).

Exclusion Criteria

* Patient already treated for prostatic carcinoma with brachytherapy, radiotherapy or focal therapy
* Patient participating in ongoing research or in a period of exclusion at the time of inclusion
* Refusal or inability to comply with the study protocol for any reason whatsoever
* Protected participant: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision.
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Elsan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Rhône Durance

Avignon, , France

Site Status NOT_YET_RECRUITING

Clinique St Vincent

Besançon, , France

Site Status RECRUITING

Clinique St Augustin

Bordeaux, , France

Site Status RECRUITING

Polyclinique Médipôle St-Roch

Cabestany, , France

Site Status RECRUITING

Polyclinique du Parc

Caen, , France

Site Status NOT_YET_RECRUITING

Pole Sante Sud-CMCM

Le Mans, , France

Site Status RECRUITING

Hôpital Privé Nancy Lorraine

Nancy, , France

Site Status NOT_YET_RECRUITING

Polyclinique Les Fleurs

Ollioules, , France

Site Status RECRUITING

Polyclinique Santé Atlantique

Saint-Herblain, , France

Site Status NOT_YET_RECRUITING

Clinique Belledonne

Saint-Martin-d'Hères, , France

Site Status RECRUITING

Centre clinical

Soyaux, , France

Site Status NOT_YET_RECRUITING

Hôpital Privé Océane

Vannes, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Charlène PY, Eng

Role: CONTACT

+33556003048

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christophe CLEMENT, MD

Role: primary

+334 90 14 81 81

Clément DARCQ, MD

Role: primary

+333 81 48 28 28

Jean-Luc HOEPFFNER, MD

Role: primary

+335 56 00 30 30

Nicolas LETANG, MD

Role: primary

+334 28 63 10 10

Rayan ATME, MD

Role: primary

+332 31 82 82 82

Olivier BELAS, MD

Role: primary

+332 43 78 38 38

Nicolas HUBERT, MD

Role: primary

+333 83 93 50 00

Olivier ALENDA, MD

Role: primary

+334 83 08 62 57

Quentin Come LE CLERC, MD

Role: primary

+332 40 95 93 93

Jean-Alexandre LONG, MD

Role: primary

+334 38 38 02 02

Olivier LAPOUGE, MD

Role: primary

+335 45 97 88 00

Hervé MONSAINT, MD

Role: primary

+332 97 62 57 30

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A01745-42

Identifier Type: OTHER

Identifier Source: secondary_id

PROSTAMBU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.